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Abstract: Four cases of primitive neuroectodermal tumors (PNETs) with unusual localization (three intraspinal extramedullary
and one pontocerebellar) are reviewed. Histologically, they were small round blue cell tumors with diverse patterns.
Immunohistochemically, all tumors were positive for at least two neuronal markers, two cases were Mic-2 positive and one
showed glial differentiation. The paraffin-embedded tumor specimens were examined by interphase FISH using dual-color
probes specific for EWS, HER-2 and BCR loci. Molecular cytogenetic study revealed the presence of EWS rearrangement in
two cases and the presence of i(17q) in one tumor. Three tumors exhibited 22 disomy and one was 22 polyploid. Extraparen-
chymal PNETs within craniospinal axis are heterogeneous from the clinical, histological, immunohistochemical and molecular
point of view. These PNETs can be of a central or peripheral type. Multidisciplinary approach is of a basic importance in
differential diagnosis of such cases.
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Introduction
Primitive neuroectodermal tumors (PNETs) comprise a
heterogeneous group of neuroepithelial small round blue
cell tumors. They can develop within or outside of the
central nervous system (CNS), being described as cen-
tral or peripheral PNETs. PNETs reveal a spectrum of
patterns evident at morphological, immunohistochemi-
cal and molecular levels [1, 17, 21, 26]. 
The most frequently diagnosed central PNET is cere-
bellar medulloblastoma, which shows isochromosome
17q as the most characteristic cytogenetic abnormality
[2, 4]. The other central PNETs are tumors morphologi-
cally undistinguishable from medulloblastoma, located
within cerebral hemispheres, pineal gland and pituitary
[17]. These PNETs show a spectrum of non-random
chromosomal structural aberrations or losses, detected
by karyotyping or by loss of heterozygosity (LOH)
allelotyping, which include deletions of chromosomes
5q, 6, 9, 10, 11, 16q and 22 [2, 3, 21]. LOH on chromo-
some 22 is also a feature of some other CNS tumors,
such as meningiomas, ependymomas, gliomas, and
atypical rhabdoid tumors [3, 4].
The peripheral PNETs belong to the pPNET/ Ewing
sarcoma group of tumors [9, 26]. They develop usually
in bones and less frequently in soft tissue of the lower
extremities, as well as within paravertebral and retro-
peritoneal regions [20, 24, 26] . This group of neoplasms
is characterized by the presence of abundant Mic-2
surface protein and common t(11;22)(q24;q12) translo-
cation [9, 17, 25]. Due to this translocation, in 85% of
cases, specific gene rearrangement occurs, leading to
EWS/FLI1 gene fusion [1, 19, 26]. In rare cases, EWS
translocates to other gene partners, creating as a conse-
quence different chimeric fusion proteins [17, 26, 29].
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Extraparenchymal PNETs localized within the cra-
niospinal axis are very rarely encountered. Only few
such cases are reported, indicating the heterogeneous
nature of these neoplasms [7, 18, 28]. We review herein
our own four cases.
Materials and methods
All cases were diagnosed at the Department of Pathology, Medical
University of Gdan´sk. Clinical history was available in each case.
Patients 1, 2 and 3 have been reported previously in separate case studies
[14-16]. Clinical data of all patients are summarized in Table 1.
Formalin-fixed, paraffin embedded tumor sections were exam-
ined histologically by routine H-E staining. 
Immunohistochemical evaluation was performed according to
standard streptavidin technique with the appropriate positive and
negative controls, using LSAB method. The following antibodies
(DAKO Glostrup, Denmark) were employed: MIC-2 (CD99), leu-
kocyte common antigen (LCA), vimentin, synaptophysin, neuron-
specific enolase (NSE), glial fibrillary antigen (GFAP), cytokeratin
AE1/AE3, Cam 5.2, epithelial membrane antigen (EMA), desmin,
α-smooth muscle actin, sarcomeric actin, myoglobin , chromogranin,
neurofilament protein, NB84 and CD56 (NCAM- Novocastra).
Interphase fluorescence in situ hybridization (FISH) was per-
formed on nuclei isolated from paraffin-embedded tissue, according
to the protocol described previously [12]. The following probe sets
were used: biotin-labeled cosmid G9 and digoxigenin-labeled cos-
mid F7 (their corresponding loci flank EWSR1/22q12 region) DNA
probes and dual-color Spectrum-Orange LSI HER-2/neu
(17q11.2)/Spectrum Green CEP17 (17p11.1-q11.1; Vysis Inc., Stutt-
gart, Germany) DNA probes. A locus- specific LSI22q (BCR) probe
was used for chromosome 22-copy enumeration. 
Hybridization and detection was performed as previously de-
scribed [9]. Hybridization signals were visualized using an epifluo-
rescence microscope (Leica DMRB, Wetzlar, Germany) equipped
with a cooled CCD camera and processed by image analysis software
(QUIPS, Vysis, IL, USA).
Results
Pathology
All cases were highly cellular, composed of mitotically
active small blue cells with high nucleo-cytoplasmic
ratio. Differential diagnosis of PNET included neuro-
blastoma, lymphoma and rhabdomyosarcoma in child-
ren, and lymphoma, poorly differentiated small cell
sarcomas and metastatic small cell carcinoma in the
adults.
Cases 1, 2, 3 had monomorphic cellular composition
with different tissue patterns: solid cohesive, creating
sheets and in case 3 complex-lobular and microcystic.
Case 4 had two cellular populations: small cells in solid
cohesive areas and larger cells in a nested pattern with
rosettes and necrosis. All cases had rich delicate vascu-
lature, made of small vessels without parietal prolifera-
tion (Fig. 1).
Histological and immunohistochemical features of
tumors are summarized in Tables 2 and 3 (Fig. 2). 
Immunostaining for cytokeratin, chromogranin,
neurofilaments, Cam5.2, EMA, desmin, ASMA, sar-
comeric actin, myoglobin, LCA and NB84 were all
negative.
FISH analysis
The results of interphase FISH studies are presented in
Table 4. In summary, FISH revealed the presence of
EWS rearrangement in two cases (case 2 and 4) and the
presence of i(17q) in one tumor (case 3). Case 4 dis-
played also overrepresentation of chromosomes 17 and
22. Most likely, the rearrangement of EWS in cases 1 and
4 indicated the presence of t(11;22), since this variant is
most common in PNET/ES family of tumors. The
presence of i(17q) in case 3 suggested the occurrence of
central PNET of medulloblastoma type (Fig. 3).
Discussion
The combination of clinical, histological and immuno-
histochemical features allows categorization of the ma-
jority of PNETs. However, in some cases an immuno-
histochemical profile is not always specific enough,
requiring the molecular approach in search for a specific
gene rearrangements, for instance toward EWS gene
involvement [5, 17, 25, 26]. 
In the presented cases, diagnosis of PNET was estab-
lished on the basis of histological and immunohisto-
chemical features of the tumor tissue. Further diagnosis
Table 1. Clinical data of patients with PNETs
Patient 1. 2. 3. 4.
Age/ sex 26 years/ male 13 years/ female 26 years/ female 9 years/ female
Site of primary tumor Intra-dural C4-6, C5 rootinfiltration
Epidural C7-Th11, dural
infiltration Cerebello-pontine angle 
Epidural Th11-L2, 
para-vertebral
Treatment Partial excision,
radiotherapy
Open biopsy, radio-
therapy, chemotherapy
Total excision
radiotherapy 
Subtotal excision, 
chemotherapy 
Metastases Dissemination via CSF Spine, lungs, bone 
marrow
Not detected Not detected
Follow-up Died 3 months after diagnosis
Died due to
dissemination after 5
years 
3.5 years, no symptoms 3.5 years, no symptoms 
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Fig. 1. Histological pictures of tumors: A - case 1, B - case 2, C - case 3, D - case 4; H-E.
Fig. 2. Immunohistochemical staining: A - case 4, strong membra-
neous CD99 reactivity; B - case 3, cytoplasmic GFAP deposits.
Fig. 3. FISH. Upper half - case 3: isochromosome 17q (association
of two red signals 17q11.2 with green signal  p11.1-q11.1). Lower
half - case 4: increased number of signals from chromosome 22
(green arrows); fusion (yellow arrows) of red (cos F7) and green
signals (cos G9) prove rearrangement of EWS region.
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was supported by FISH analysis, which revealed mole-
cular differences between these tumors. Two tumors
showed rearrangement of EWS gene characteristic for
pPNET/ ES, one had iso17q typical for medulloblasto-
ma, and in one no changes were found with the applied
probes. Loss of heterozygosity in chromosome 22 was
not revealed in any case. Case 4, however, showed EWS
rearrangement together with polyploidy of chromo-
somes 17 and 22. 
Several extraparenchymal CNS PNETs of leptomen-
ingeal, dural and of nerve root origin have been reported
up to now [7, 10, 13, 28]. Only in some of them mole-
cular analysis was performed despite of the fact that this
information carries therapeutic and prognostic implica-
tions [7, 13]. The paper of Dedeurwaerdere et al. [7]
yields a current review of literature concerning dural
intracranial and intraspinal cases with t(11;22). Pre-
viously Deme et al. [8] presented the review of 13 cases
of spinal intramedullary and intradural PNETs from the
literature, but cytogenetic data were unavailable there.
Similarly, most of several reported pontocerebellar me-
dulloblastomas in adults lack cytogenetic or molecular
analysis, so it seems that some of them are in fact
intracranial cases of PNET/ES [18, 27].
All our patients were under 40 years of age, similarly
to the literature reports [7, 10, 18, 28]. Three of our
tumors had intraspinal extramedullary location. Case 1
probably originated from cervical nerve root or spinal
dura. Cases 2 and 4 were lumbar epidural tumors (the
first with dural implants and systemic metastases, and
the second with extension into the paraspinal muscles).
The intracranial case 3, which was clinically manifested
as meningioma seemed to be in fact an extracerebellar
medulloblastoma. Two patients died due to neoplastic
dissemination, and two, who were free of metastases at
the clinical presentation, are alive and asymptomatic.
Although the long clinical course is reported in up to
45% to 60% of PNET-ES cases, general prognosis is bad
[23, 24]. An aggressive growth with extension into the
paraspinal muscles and progression with CSF seeding or
Table 2. Histological features of the examined tumors
Case 1. 2. 3. 4.
Cells Round, elongated Round, oval Round, carrot-shaped Round- small and large
Tissue pattern Solid cohesive Sheets, lobules Lobular, microcystic Solid, nested
Rosettes Scattered Scattered Scattered Scattered 
Necrosis Focal – Focal Focal 
Vessels Delicate Delicate Delicate Delicate
PAS staining – – – Focal
Table 3. Immunostaining of the examined tumors
Case 1. 2. 3. 4.
NSE Focal + + +
Synaptophysin Focal + – +
GFAP – – + –
NCAM – + + –
S100 + + + +
Mic-2 – + – +
Vimentin – – – Focal
Table 4. FISH results in the examined tumors
Probes
Case
1 2 3 4
EWS flanking probes No rearrangement Rearranged No rearrangement Rearranged
Iso 17q Absent Absent Present Absent, 17 poliploidy
BCR(22q12)loci 22 disomy 22 disomy 22 disomy 22 poliploidy
Final diagnosis PNET not otherwise 
specific PPNET/ES Central PNET-MB PPNET/ES
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distant metastases is characteristic for these neoplasms
[8, 10, 20, 23]. Among patients with intracranial central
PNETs, long-term survival is uncommon, although
adult medulloblastomas show better prognosis [17, 22].
The known prognostic factor is the stage of the disease
at the diagnosis [23, 24].
Neural differentiation is characteristic and diagnostic
for most of PNETs and is also accepted as the feature
distinguishing pPNET from ES in this family of tumors
[13, 20, 24]. Schmidt et al. [24] defined pPNET by the
presence of rosettes or immunoreactivity with at least
two neuronal markers. All our tumors showed these
features. Our pontocerebellar medulloblastoma
presented in part an unusual microcystic pattern. The
parallel expression of GFAP and neuronal markers re-
vealed bipotential differentiation in this tumor. In the
study of Nicholson et al. [21] on central PNETs, tumors
with i17q were GFAP- negative. Amann et al. [1] exam-
ined relation of neuroglial marker expression and EWS
gene fusion types in osseous PNET/ES. Only few of
their cases were immunopositive for more than two
neuroglial markers and a correlation of immunopheno-
type with molecular features was not found. The authors
observed, however, some relations between fusion type
and tumor histology. The morphology of our case 2 was
quite typical for PNET, since case 4 showed multiple
molecular changes together with complex histological
features.
The Mic-2 gene product (CD99) is highly expressed
in nearly all peripheral PNET-ES but it is not their
specific marker [5, 11]. Central PNETs are CD99-nega-
tive [7, 13, 17]. Both our tumors with EWS rearrange-
ment showed Mic-2 expression. In one of them, NCAM
reactivity was found. This was rather an unusual finding,
since commonly an inverse correlation exists between
these two markers [11]. 
Lack of EWS rearrangement and Mic-2 expression in
case 1 most likely excludes diagnosis of pPNET/ES [25,
26], although the presence of another translocation vari-
ant can not be ruled out [29]. It can be also a central type
tumor with changes not detectable by our probes. Cur-
rent literature on central PNET analysis with com-
parative genomic hybridization, spectral karyotyping
and FISH [2, 3] shows involvement of different chromo-
somes including 7, 17, 10 and 22.
Extraparenchymal PNETs within craniospinal axis
are heterogeneous from the clinical, histological, immu-
nohistochemical and molecular point of view. In addi-
tion to immunohistochemistry, these tumors need to be
diagnosed with molecular methods to resolve diagnostic
difficulties and to optimize the therapy. 
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